Subject Enrollment. Principal Investigator and Institution (through the actions of the Principal Investigator) have agreed to enroll qualified Study participants during the Pfizer-specified enrollment period, unless CRO, upon Pfizer’s prior instructions, modifies the enrollment period by written notice. A qualified participant is one who meets all Protocol criteria for inclusion in the Study (“Study Subject”).
Appears in 4 contracts
Samples: Clinical Study Agreement, Clinical Study Agreement, Clinical Study Agreement
Subject Enrollment. Institution has agreed through Principal Investigator and Institution (through the actions of the Principal Investigator) have agreed to enroll qualified Study participants during the Pfizer-specified enrollment period, unless CRO, upon Pfizer’s prior instructions, modifies the enrollment period by written notice. A qualified participant is one who meets all Protocol criteria for inclusion in the Study (“Study Subject”).
Appears in 2 contracts
Subject Enrollment. Principal Investigator and Institution (through the actions of the Principal Investigator) have agreed to enroll qualified Study participants during the Pfizer-specified enrollment period, unless CRO, upon Pfizer’s prior instructions, modifies the enrollment period by written notice. A qualified participant is one who meets all Protocol criteria for inclusion in the Study (“Study Subject”).
Appears in 2 contracts
Subject Enrollment. Principal Investigator and Institution (through the actions of the Principal Investigator) have agreed to enroll qualified Study participants during the Pfizer-specified enrollment period, unless CRO, upon Pfizer’s prior instructions, modifies the enrollment period by written notice. A qualified participant is one who meets all Protocol criteria for inclusion in the Study (“Study Subject”). zdokumentovaných podmienok.
Appears in 1 contract
Samples: Clinical Study Agreement
Subject Enrollment. Institution has agreed through Principal Investigator and Institution (through the actions of the Principal Investigator) have agreed to enroll qualified Study participants during the Pfizer-Pfizer- specified enrollment period, unless CRO, upon Pfizer’s prior instructions, modifies the enrollment period by written notice. A qualified participant is one who meets all Protocol criteria for inclusion in the Study (“Study Subject”).
Appears in 1 contract
Samples: Clinical Study Agreement